Kyle Wooderson, DO
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (49.6%), education and food and beverage — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 85.7% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2024 at $9,525 and has fallen 80.6% since, to $1,851 in 2025.
Across 67 payments — averaging $192.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$11K
- BD$818
- Stryker$524
- Davol Inc.$311
- Organogenesis Inc.$37
- AbbVie$29
- plus $119 from 8 others
What the payments were for
- Travel & lodging$6,39050%
- Food & beverage$1,46111%
- Education$5,02639%
- Gifts$90%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 44 | $11,049 |
| BD | 4 | $818 |
| Stryker | 1 | $524 |
| Davol Inc. | 7 | $311 |
| Organogenesis Inc. | 2 | $37 |
| AbbVie | 1 | $29 |
| Conmed Corporation | 1 | $20 |
| Medtronic | 1 | $18 |
| Smith+Nephew | 1 | $16 |
| KCI USA, Inc. | 1 | $16 |
| Phathom Pharmaceuticals, Inc. | 1 | $13 |
| Polynovo North America LLC | 1 | $13 |
| Braintree Laboratories, Inc. | 1 | $12 |
| TEI Biosciences Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$5,589
- DAVINCI XI$5,000
- Phasix Mesh$903
- 1688$524
How this compares
$12,886 in reported general payments places this provider in the 85th percentile of 290 surgery providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 149 | $9,362 |
| Esomeprazole Magnesium | 48 | $2,109 |
| Pantoprazole Sodium | 169 | $1,849 |
| CholestyramineCholestyramine (With Sugar) | 11 | $1,715 |
| Sucralfate | 67 | $1,553 |
| Omeprazole | 84 | $880 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 27 | $268 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 12 | $109 |
| Tramadol Hcl | 24 | $99 |
Paid to pharmacies, not to this prescriber.
Other surgery in Grove
- Haley AdamsGrove$9K
- Craig JohnsonTulsa$573K
- Eugene DickensTulsa$456K
- William JenningsTulsa$412K
- John LangClaremore$160K
- Bryce MurrayTulsa$152K
- Steven FeherTulsa$50K
- Samuel PangburnTulsa$50K
- Jared LepleyTulsa$48K
- Christopher CareyOklahoma City$39K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.